Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Akebia Therapeutics Inc. buy BTIG Research

Akebia Therapeutics Inc.
Start price
€1.08
25.02.26 / 50%
Target price
€3.39
25.02.27
Performance (%)
10.55%
Price
€1.20
09.04.26
Summary
This prediction is currently active. The prediction currently has a performance of 10.55%. This prediction currently runs until 25.02.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Akebia Therapeutics Inc. 0.672% 0.672%
iShares Core DAX® 2.554% -0.112%
iShares Nasdaq 100 2.742% -0.470%
iShares Nikkei 225® 6.584% 3.221%
iShares S&P 500 1.930% -0.519%

Comments by BTIG_Research for this prediction

In the thread Akebia Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 10.55%
Target price 3.394
Change
Ends at 25.02.27

Akebia Therapeutics (AKBA) had its price target lowered by BTIG Research from $5.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for AKBA provided by MarketBeat

BTIG Research 
0
Report Share
25.02.26

Stopped prediction by BTIG_Research for Akebia Therapeutics Inc.

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.18
07.04.26
€3.47
07.04.27
1.96%
09.04.26

BTIG Research 
07.04.26 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.27
02.12.25
€4.31
02.12.26
-6.63%
09.04.26

BTIG Research 
02.12.25 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.93
29.10.25
€4.29
29.10.26
-38.30%
09.04.26

BTIG Research 
29.10.25 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.92
29.11.23
€3.64
29.11.24
122.78%
30.11.24

BTIG Research 
29.11.23 50%